Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing · New Jersey

Sanofi Ridgefield

Ridgefield, NJ · ~293 workers · 3 years of OSHA Injury Tracking Application data.

A
Excellent Safety Record
0.6
Avg TCR
3.3
Industry avg
0
Fatalities
Subscribe to safety-record updates (RSS)

The verdict

Sanofi Ridgefield runs at 18% of its industry's injury rate - far safer than the typical Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing workplace, earning a grade A.

Sanofi Ridgefield: 0.6 TCR = 18% of Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing BLS 3.3 · 3y Form 300A (see methodology below)

Sanofi Ridgefield safety composite

Sanofi Ridgefield scores strongest on total case rate (tcr) (safer than 84% of same-industry peers) and weakest on fatalities (safer than 50%), blended into one 0-100 breakdown against same-industry peers. A missing measure drops out and redistributes its weight rather than deflating the score. This is a per-dimension breakdown, distinct from the single letter grade above it (which weights TCR alone against the BLS industry benchmark).

B

75/100

Percentile-weighted across 3 of 3 measures

Total Case Rate (TCR)
B 0.58 per 100 workers

Safer than 84% of industry peers

DART rate
B 0 per 100 workers

Safer than 83% of industry peers

Fatalities
D 0

Safer than 50% of industry peers

Benchmarked live against every credibly-rated employer in the same NAICS industry code in the current OSHA extract (a segment must have at least 8 rated peers to benchmark). Not a legal or compliance determination; PlainSafetyScore's own weighting (TCR 40%, DART 35%, fatalities 25%).

TCR Δ

−1.1

2017→2019

Sanofi Ridgefield injury rate improved

Sanofi Ridgefield's TCR fell 1.1 from 1.1 in 2017 to 0.0 in 2019. Peak filing year was 2017 at 1.1 TCR. In 2019, DART was 0× this establishment's average TCR (severity share of cases).

2017=1.1 · 2018=0.6 · 2019=0.0

OSHA ITA Form 300A scorecard

Establishment book 325412 · Ridgefield, NJ AT/BELOW-IND · MID

Grade A · TCR 0.6 · 18% of ind

  • DART 0.0 DART
  • RANK #11/93
  • PHOTO Allergan Inc
  • BOOK 3y book
  • INJ 5 inj
  • SIZE ~293 FTE

Nearest TCR peer: Allergan Inc (0.0 TCR gap)

Read with this employer → · Industry book → · New Jersey employers → · Look up another →

Sanofi Ridgefield in the TCR neighbourhood

Average Total Case Rate among this establishment and nearest same-industry peers

TCR

What this shows Sanofi Ridgefield averages 0.6 TCR (18% of the Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing BLS benchmark).

Source U.S. Department of Labor, OSHA Injury Tracking Application (Form 300A) As of 2026-08-25

Sanofi Ridgefield TCR series: 2017=1.1 · 2018=0.6 · 2019=0 · BLS 3.3

Where Sanofi Ridgefield falls in its industry

855 Pharmaceutical preparations (e establishments

Safer than 84% of graded establishments in this industry, whose median TCR is 1.6.

More dangerous than peersSafer than peers

Narrower to New Jersey alone (the establishments it most directly competes with for workers and contracts): ranked #11 safest of 93 Pharmaceutical preparations (e employers in New Jersey.

Sanofi Ridgefield (293 employees, TCR 0.6) among 29 same-industry peers, split at the industry median of 171 employees and a TCR of 1.6 2×2 strategic matrix plotting 30 entities by Average employees (X) and Total Case Rate (Y), with a crosshair dividing the plot into four quadrants. Larger & higher-riskSmaller & higher-riskLarger & saferSmaller & safer than peers 01,0002,0003,0004,000 051015 Average employees Total Case Rate Sanofi Ridgefield
Sanofi Ridgefield (293 employees, TCR 0.6) among 29 same-industry peers, split at the industry median of 171 employees and a TCR of 1.6

Sanofi Ridgefield has more employees than the Pharmaceutical preparations (e.g., capsu median and a lower injury rate than the industry's median TCR of 1.6. Workforce size and injury rate do not always move together within the same industry -- some of its smaller peers run higher rates than its larger ones, and vice versa.

Year-by-Year Safety Data

Year TCR DART Injuries Illnesses Fatalities
2019 0.0 0.0 0 0 0
2018 0.6 0.3 2 0 0
2017 1.1 0.7 3 0 0

OSHA ITA peer cross-reference

Establishment peer ledger

325412 · NJ · Ridgefield

855 Pharmaceutical preparations (e.g., capsules, liniments, ointments, tablets) manufacturing employers nationwide with a credible TCR · 11,201 rated employers in New Jersey with headcount on file · 23 employers in Ridgefield, NJ · 4 cross-state NAT-TCR peers · 4 cross-state NAT-SIZE peers. Closest matches by relationship code are listed below.

Rel Establishment Metric
NAICS-TCR Allergan Inc 0.6 TCR
NAICS-TCR Boehringer Ingelheim Animal Health Puerto Rico LLC 0.6 TCR
NAICS-TCR Fougera Pharmaceuticals Melville Site 0.6 TCR
NAICS-TCR Lantheus Medical Imaging 0.6 TCR
STATE-SIZE Skanska Kiewit - SKK Bayonne Bridge 293 FTE
STATE-SIZE Hatteras Press Inc. 293 FTE
STATE-SIZE L'Oreal USA Products, Inc. - Piscataway 293 FTE
STATE-SIZE 72006 293 FTE
CITY-NEAR Voyant Beauty Ridgefield 289 FTE
CITY-NEAR Sanofi 262 FTE
CITY-NEAR Ridgefield 159 FTE
CITY-NEAR HAR Ridgefield, Corp. 125 FTE
NAT-TCR Minerva Manufacturing Facility 0.6 TCR
NAT-TCR Truck Accessories Group, L.L.C dba Pace Edwards Company 0.6 TCR
NAT-TCR PSC Industrial Outsourcing, LP-EBR 0.6 TCR
NAT-TCR H.B. Frazer Company 0.6 TCR
NAT-SIZE Main Office Building Annex 293 FTE
NAT-SIZE North America Fulfillment Centers (FCs) : MSN5 293 FTE
NAT-SIZE PA0479CBC 293 FTE
NAT-SIZE Powerline Services 293 FTE

Rel codes: NAICS-TCR · STATE-SIZE · CITY-NEAR · NAT-TCR/NAT-SIZE cross-state. Read with this employer →

Data Source: OSHA Injury Tracking Application (ITA), mandatory establishment-level injury/illness reports. Grades compare employer Total Case Rate (TCR) to BLS IIF industry benchmarks. Data covers years reported by this establishment: 2019, 2018, 2017. This is publicly available government data - not a legal determination of workplace conditions.
Data sourced from official public datasets. See our methodology for details.